Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Warner

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Psychiatry & Neuroscience : JPN|June 1, 1992
50 kD prolactin binding protein in schizophrenics on neuroleptic medicationA M Walker, C A Peabody, T W Ho, et al.
Journal of the American Geriatrics Society|March 1, 1987
Neuroleptics and the elderlyC A Peabody, M D Warner, H A Whiteford, et al.
The Journal of Clinical Psychiatry|June 1, 1987
Trazodone and priapismM D Warner, C A Peabody, H A Whiteford, et al.
The Journal of Nervous and Mental Disease|March 1, 1990
Alprazolam and withdrawal seizuresM D Warner, C A Peabody, N N Boutros, et al.
Psychoneuroendocrinology|October 1, 1992
The effect of haloperidol on aldosterone secretionM D Warner, H Gillespie, S N Pavlou, et al.
Computer Methods in Biomechanics and Biomedical Engineering|October 30, 2004
Bone remodelling of a proximal femur with the thrust plate prosthesis: an in vitro caseW R Taylor, H Ploeg, D Hertig, et al.
Journal of Affective Disorders|May 1, 1987
Elevated baseline and postdexamethasone cortisol levels. A reflection of severity or endogeneity?H A Whiteford, C A Peabody, J G Csernansky, et al.
The Medical Journal of Australia|September 7, 1987
Maintenance therapies in schizophreniaH A Whiteford, C A Peabody, M D Warner, et al.
Psychiatry Research|July 7, 2001
Lower prolactin bioactivity in unmedicated schizophrenic patientsM D Warner, A M Walker, D C D'Souza, et al.
Psychiatry Research|September 1, 1990
Growth hormone response to growth hormone releasing hormone in depression and schizophreniaC A Peabody, M D Warner, E Markoff, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Psychiatry & Neuroscience : JPN|June 1, 1992
50 kD prolactin binding protein in schizophrenics on neuroleptic medicationA M Walker, C A Peabody, T W Ho, et al.
Journal of the American Geriatrics Society|March 1, 1987
Neuroleptics and the elderlyC A Peabody, M D Warner, H A Whiteford, et al.
The Journal of Clinical Psychiatry|June 1, 1987
Trazodone and priapismM D Warner, C A Peabody, H A Whiteford, et al.
The Journal of Nervous and Mental Disease|March 1, 1990
Alprazolam and withdrawal seizuresM D Warner, C A Peabody, N N Boutros, et al.
Psychoneuroendocrinology|October 1, 1992
The effect of haloperidol on aldosterone secretionM D Warner, H Gillespie, S N Pavlou, et al.
Computer Methods in Biomechanics and Biomedical Engineering|October 30, 2004
Bone remodelling of a proximal femur with the thrust plate prosthesis: an in vitro caseW R Taylor, H Ploeg, D Hertig, et al.
Journal of Affective Disorders|May 1, 1987
Elevated baseline and postdexamethasone cortisol levels. A reflection of severity or endogeneity?H A Whiteford, C A Peabody, J G Csernansky, et al.
The Medical Journal of Australia|September 7, 1987
Maintenance therapies in schizophreniaH A Whiteford, C A Peabody, M D Warner, et al.
Psychiatry Research|July 7, 2001
Lower prolactin bioactivity in unmedicated schizophrenic patientsM D Warner, A M Walker, D C D'Souza, et al.
Psychiatry Research|September 1, 1990
Growth hormone response to growth hormone releasing hormone in depression and schizophreniaC A Peabody, M D Warner, E Markoff, et al.
Pageof 4